(Q34166985)

31 July 2017

1 reference

title

Understanding pruritus in systemic disease (English)

1 reference

31 July 2017

Krajnik M

1

1 reference

31 July 2017

Zylicz Z

series ordinal

2

1 reference

31 July 2017

publication date

1 February 2001

1 reference

Journal of Pain and Symptom Management

31 July 2017

published in

1 reference

31 July 2017

volume

21

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

151-168

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

31 July 2017

1 reference

7 January 2021

Pruritus--itching for a cause and relief?

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

1 reference

7 January 2021

Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

The intradermal effects of the H3 receptor agonist R α methylhistamine in human skin.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Histamine H3 receptor-mediated inhibition of serotonin release in the rat brain cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Histamine-caused itch induces Fos-like immunoreactivity in dorsal horn neurons: effect of morphine pretreatment

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Some methods for evaluating clinical itch and their application for studying pathophysiological mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

1 reference

7 January 2021

Can a serotonin type 3 (5-HT3) receptor antagonist reduce experimentally-induced itch?

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Pruritus of polycythaemia vera: a place for pizotifen?

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Whole blood serotonin levels are markedly elevated in patients on dialytic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Naloxone modulates the perception of itch in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

The antipruritic effect of a 5-HT3 receptor antagonist (tropisetron) is dependent on mast cell depletion--an experimental study

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Itching for an explanation

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Conditioning of histamine by bradykinin alters responses of rat nociceptor and human itch sensation

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

The gate control theory of pain mechanisms. A re-examination and re-statement

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Improved device for measuring scratching activity in patients with pruritus

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Generalized pruritus and systemic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

1 reference

7 January 2021

Relief of pruritus and decreases in plasma histamine concentrations during erythropoietin therapy in patients with uremia

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

The effect of azelastin hydrochloride on pruritus and leukotriene B4 in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Effects of azelastin on pruritus and plasma histamine levels in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Thalidomide for the treatment of uremic pruritus: a crossover randomized double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Topical capsaicin for treatment of hemodialysis-related pruritus

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Oral activated charcoal in patients with uremic pruritus

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Cholestyramine in uraemic pruritus

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

UV treatment of uraemic pruritus reduces the vitamin A content of the skin

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Identifying effective treatments for uremic pruritus

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Randomised crossover trial of naltrexone in uraemic pruritus

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Intraepidermal neuron-specific enolase (NSE)-immunoreactive nerve fibres: evidence for sprouting in uremic patients on maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Postoperative ulnar neuropathy after kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Intractable pruritus as a manifestation of secondary hyperparathyroidism in uremia. Disappearance of itching after subtotal parathyroidectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Uremic pruritus: roles of parathyroid hormone and substance P

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

1 reference

7 January 2021

Disappearance of uraemic pruritus after lowering dialysate magnesium concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Dialysis pruritus: effect of cimetidine

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

The pruritus of cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Oral naltrexone treatment for cholestatic pruritus: A double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Codeine for pruritus in primary billiary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Relief of cholestatic pruritus by a novel class of drugs: 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists: effectiveness of ondansetron

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Opioid antagonists in the treatment of pruritus from cholestatic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Subhypnotic doses of propofol relieve pruritus associated with liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Rifampicin as treatment for pruritus in malignant cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

A combination of phototherapy and cholestyramine for the relief of pruritus in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Long-term treatment with interferon-alpha 2b for severe pruritus in patients with polycythaemia vera

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Letter: Relief of intractable pruritus in polycythaemia rubra vera with cholestyramine

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Should the patient with generalized pruritus be evaluated for malignancy?

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Severe pruritus should be a B-symptom in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Itch and malignancy prognosis in generalized pruritus: a 6-year follow-up of 125 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Pruritus as a presentation of myelomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Pruritic specific cutaneous infiltrates in leukemia and lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Cimetidine for pruritus in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Iron-deficiency pruritus

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Cutaneous Manifestations of Hyperthyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Pruritus in diabetes mellitus: investigation of prevalence and correlation with diabetes control

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Pruritus, an uncommon but important symptom of systemic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Skin manifestations associated with tumours of the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Decreased skin response to intradermal histamine in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Itching after epidural and spinal opiates

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Intrathecal diamorphine for analgesia after caesarean section. A dose finding study and assessment of side-effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Epidural morphine for analgesia after caesarean section: a report of 4880 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Eyelid pruritus with intravenous morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Intracisternal injection of opioids induces itch-associated response through mu-opioid receptors in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Intraspinal opiates and itching: a new reflex?

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Serotonin and nociception

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Ondansetron is effective to treat spinal or epidural morphine-induced pruritus.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

The use of ondansetron to treat pruritus associated with intrathecal morphine in two paediatric patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Nalbuphine is better than naloxone for treatment of side effects after epidural morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Transnasal butorphanol for the treatment of opioid-induced pruritus unresponsive to antihistamines

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Butorphanol-induced pruritus antagonized by naloxone

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Multiple effects of morphine on facial scratching in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Mechanism of action of antipruritic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Comparison of histamine release in human skin mast cells induced by morphine, fentanyl, and oxymorphone.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Opioid-induced itching: morphine sulfate and hydromorphone hydrochloride

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

The effect of rectal diclofenac on pruritus in patients receiving intrathecal morphine.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Paroxysmal itching in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Unilateral neurogenic pruritus following stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Unilateral pruritus and Nocardia brain abscess.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Notalgia paraesthetica--report of three cases and their treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Treatment of notalgia paresthetica with topical capsaicin

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Letter: Post-herpetic pruritus

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

1 reference

7 January 2021

Increased cutaneous fibrinolytic activity in aquagenic pruritus

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Treatment of aquagenic pruritus with topical capsaicin cream

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

The efficacy of psoralen photochemotherapy in the treatment of aquagenic pruritus

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Pruritus secondary to hydroxyurea therapy in a woman with polycythemia vera

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Successful treatment of hydroxyethyl starch-induced pruritus with topical capsaicin

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Comparison of photochemotherapy and dithranol in the treatment of chronic plaque psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Treatment of PUVA itch with capsaicin

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Prevalence and clinical spectrum of skin disease in patients infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Pruritic papular eruption in HIV seropositive patients: a cutaneous marker for immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Clinical significance of eosinophilia in HIV-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Distinct serum cytokines in AIDS-related skin diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Intractable pruritus in HIV infection: immunologic characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Generalized pruritus. A study of 43 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Hypnosis in a case of long-standing idiopathic itch.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Histamine and serotonin in uremic pruritus: effect of ondansetron in CAPD-pruritic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Management of opioid-induced pruritus: a role for 5-HT3 antagonists?

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Relief of uremic pruritus with ultraviolet phototherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Itching--research has barely scratched the surface

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron: a randomized, placebo-controlled, double-blind cross-over trial

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Activated charcoal rediscovered.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

Uremic pruritus: an unresolved problem in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900256-6

7 January 2021

10.1016/S0885-3924(00)00256-6

Identifiers

DOI

1 reference

31 July 2017

1 reference